NeuroMetrix Rceives GSK 'Bridge' For Quell Wearable Pain-Relief Development

Recent modifications accelerated portion of milestones remaining in firms' agreement over the next 12 months, reduced GSK's aggregate amount payable and forwarded $2m to NeuroMetrix. Firms are co-funding future development of Quell technology and additional TENS products for chronic pain beginning in 2019.

NeuroMetrix Inc. has received a $2m advance from GlaxoSmithKline PLC in a modification of the firms' agreement for GSK to provide up to $13.8m funding for development and commercialization of NeuroMetrix' Quell wearable pain-relief technology.

The modifications announced Dec. 11 accelerated a portion of milestones remaining in the firms' agreement over the next 12 months...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

Subscription Plot Twist Featured In Herbalife’s ‘Next Chapter’ With Pro2col Digital Platform

 

More than 7,000 distributors started a beta iteration of Pro2col in July Platform’s availability to additional US distributors =is planned for October, when it will launch with a Herbalife brand name.

UK’s ProBiotix Health Launches Menopause And Post-Menopause Supplements

 
• By 

YourBiotixMH and YourBiotixPMH “offer unique multi-positioning functionality, targeting not only cardiovascular health but also addressing key health risks associated with menopause and post-menopause, including mood imbalances, psychological challenges and bone loss,” according to ProBiotix Health.

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By 

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By 

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

More from Wellness

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By 

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By 

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.